Godecke, E., Armstrong, E. A, Middleton, S. J, Whitworth, A., Ciccone, N., Rai, T., Rose, M., Holland, A., Ellery, F., Hankey, G. J, Cadilhac, D. A & Bernhardt, J. (2016). A randomized controlled trial of very early rehabilitation in speech after stroke. International Journal of Stroke,11(5), 586-592. United Kingdom: SAGE. Retrieved from https://doi.org/10.1177/1747493016641116
The Very Early Rehabilitation of Speech (VERSE) trial aims to determine if intensive prescribed aphasia therapy (VERSE) is more effective and cost saving than non-prescribed, intensive (usual care-plus) and non-intensive usual care (UC) therapy when started within 15 days of stroke onset and continued daily over four weeks. We hypothesize that aphasia therapy when started very early after stroke and delivered daily could enhance recovery of communication compared with UC.
Access may be restricted.